Article
Targeting cancer stem cells in squamous cell carcinoma
1 Sept 2019
Abstract excerpt
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive tumor and the sixth most common cancer worldwide. Current treatment strategies for HNSCC are surgery, radiotherapy, chemotherapy, immunotherapy or combinatorial therapies. However, the overall 5-year survival rate of HNSCC patients remains at about 50%. Cancer stem cells (CSCs), a small population among tumor cells, are able to self-renew and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
